Urinary excretion of meperidine and normeperidine in man upon acute and chronic exposure to high altitude.
The urinary excretion of unchanged meperidine (M) varies with change of pH and metabolism. Since exposure of man to high altitude (H) may cause significant physiologic changes, we investigated its effects on the urinary excretion of M. The study was carried out in 3 groups of healthy, male volunteers (ages 18-20 years): at sea level (L), at 4360 m the day after arrival at H (HA), and at 4360 m in subjects residing for > 10 months at H (HC). Urine was collected for the periods of 0-4, 4-8, 8-12 and 12-24 h. Urinary pH was measured and the concentrations of M and normeperidine (N) were determined. The 24 h excretion of M and N was significantly decreased for L vs. HA and L vs. HC. Significance was also seen for the periods 0-4, 4-8 and 8-12 h. The ratio of amount excreted M/N for the 24 h period was highly significant for L vs. HA and L vs. HC. The urinary pH ranged from 5.3-5.9 for L, 5.9-7.0 for HA, and 5.1-5.7 for HC. The Fel (fraction of M eliminated in the unchanged form in urine) significantly decreased from L to HA and HC.
Ritschel
W A
WA
University of Cincinnati Medical Center, OH 45267-0004, USA.
Paulos
C
C
Arancibia
A
A
Pezzani
M
M
Agrawal
M
M
Wetzelsberger
K
K
Lücker
P W
PW
D000293:Adolescent; D000328:Adult; D000531:Altitude; D000701:Analgesics, Opioid / Q000097:blood / Q000378:metabolism / Q000652:urine*; D000704:Analysis of Variance; D002800:Cholinesterase Inhibitors / Q000652:urine; D006801:Humans; D006863:Hydrogen-Ion Concentration; D008297:Male; D008614:Meperidine / Q000031:analogs & derivatives / Q000097:blood / Q000378:metabolism / Q000652:urine*
D000701:Analgesics, Opioid; D002800:Cholinesterase Inhibitors; D008614:Meperidine; C002752:normeperidine